Posted On: 03/11/2014 12:34:25 PM
Post# of 36729
The Journal Cell indicates that " the beneficial effects of decreasing beta-amyloid plaques and neurodegeneration by delta9-THC in Alzheimer’s disease animals are retained in the presence of COX-2 inhibition. These results suggest that the applicability of medical marijuana would be broadened by concurrent inhibition of COX-2".
So, by adding COX-2 inhibitors is the simple answer to make Alzatrex a blockbuster Alzheimer's neuro-degenerative disease therapy.
I'm still concerned about the synaptic impairment and memory impairment because of delta9- thc.
I'm still concerned about the synaptic impairment and memory impairment because of delta9- thc.
It's a bit to study. That report by Cell costs $31.50 and has time constraints.
(0)
(0)
